Novel Rapid-Acting Drug Proves Effective in Severe PTSD

(MedPage Today) — Investigational neuroplastogen TSND-201 showed significant efficacy in patients with severe post-traumatic stress disorder (PTSD), according to results of a randomized phase II trial. Among 65 patients, treatment with…